Detailed Information on Publication Record
2022
The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments
SOLÁR, Peter, Alemeh ZAMANI, Klaudia LAKATOSOVÁ and Marek JOUKALBasic information
Original name
The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments
Authors
SOLÁR, Peter (703 Slovakia, belonging to the institution), Alemeh ZAMANI (364 Islamic Republic of Iran, belonging to the institution), Klaudia LAKATOSOVÁ (703 Slovakia, belonging to the institution) and Marek JOUKAL (203 Czech Republic, guarantor, belonging to the institution)
Edition
FLUIDS AND BARRIERS OF THE CNS, LONDON, BMC, 2022, 2045-8118
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30103 Neurosciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 7.300
RIV identification code
RIV/00216224:14110/22:00126060
Organization unit
Faculty of Medicine
UT WoS
000780995700001
Keywords in English
Subarachnoid hemorrhage; Blood-brain barrier; Subarachnoid hemorrhage treatment; Neuronal injury; Neurovascular unit; Neuroinflammation
Tags
Reviewed
Změněno: 16/1/2023 14:09, Mgr. Tereza Miškechová
Abstract
V originále
The response of the blood-brain barrier (BBB) following a stroke, including subarachnoid hemorrhage (SAH), has been studied extensively. The main components of this reaction are endothelial cells, pericytes, and astrocytes that affect microglia, neurons, and vascular smooth muscle cells. SAH induces alterations in individual BBB cells, leading to brain homeostasis disruption. Recent experiments have uncovered many pathophysiological cascades affecting the BBB following SAH. Targeting some of these pathways is important for restoring brain function following SAH. BBB injury occurs immediately after SAH and has long-lasting consequences, but most changes in the pathophysiological cascades occur in the first few days following SAH. These changes determine the development of early brain injury as well as delayed cerebral ischemia. SAH-induced neuroprotection also plays an important role and weakens the negative impact of SAH. Supporting some of these beneficial cascades while attenuating the major pathophysiological pathways might be decisive in inhibiting the negative impact of bleeding in the subarachnoid space. In this review, we attempt a comprehensive overview of the current knowledge on the molecular and cellular changes in the BBB following SAH and their possible modulation by various drugs and substances.
Links
EF16_027/0008360, research and development project |
| ||
MUNI/A/0975/2019, interní kód MU |
| ||
MUNI/A/1520/2020, interní kód MU |
| ||
ROZV/23/LF14/2019, interní kód MU |
|